Toolkit/calcium and fluorescent imaging

calcium and fluorescent imaging

Assay Method·Research·Since 2023

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

In combination with calcium and fluorescent imaging, functional alterations caused by mutations in epilepsy genes can be traced.

Usefulness & Problems

Why this is useful

Calcium and fluorescent imaging are presented as methods to trace functional alterations caused by epilepsy-gene mutations. In the review context, they provide readouts downstream of genetic or optogenetic perturbation.; tracing functional alterations caused by mutations in epilepsy genes

Source:

Calcium and fluorescent imaging are presented as methods to trace functional alterations caused by epilepsy-gene mutations. In the review context, they provide readouts downstream of genetic or optogenetic perturbation.

Source:

tracing functional alterations caused by mutations in epilepsy genes

Problem solved

These methods help connect mutations in epilepsy genes to observable functional changes. They add mechanistic readouts beyond gross behavioral phenotypes.; provides a way to observe functional consequences of epilepsy-gene mutations

Source:

These methods help connect mutations in epilepsy genes to observable functional changes. They add mechanistic readouts beyond gross behavioral phenotypes.

Source:

provides a way to observe functional consequences of epilepsy-gene mutations

Problem links

provides a way to observe functional consequences of epilepsy-gene mutations

Literature

These methods help connect mutations in epilepsy genes to observable functional changes. They add mechanistic readouts beyond gross behavioral phenotypes.

Source:

These methods help connect mutations in epilepsy genes to observable functional changes. They add mechanistic readouts beyond gross behavioral phenotypes.

Published Workflows

Objective: Generate and analyze Drosophila models carrying disease-associated epilepsy variants in order to interpret pathogenic consequences, study seizure-related phenotypes, and explore therapeutic implications.

Why it works: The review abstract describes a linked workflow in which disease-associated variants are introduced into flies, then screened for organism-level seizure-related phenotypes and drug responses, and further interrogated with optogenetic and imaging methods to trace functional alterations.

seizure inductionneuronal activity modulationmutation-associated functional alteration tracinggene editingphenotypic screeningbehavioral screeningdrug-response screeningoptogeneticscalcium imagingfluorescent imaging

Stages

  1. 1.
    Generate flies carrying disease-associated variants(library_build)

    This stage creates the fly models needed for downstream epilepsy phenotyping and functional analysis.

    Selection: Introduction of disease-associated variants into Drosophila using gene editing techniques such as CRISPR/Cas9.

  2. 2.
    Screen variant-carrying flies for seizure-related phenotypes and drug responses(broad_screen)

    This stage identifies observable consequences of disease-associated variants and potential therapeutic-response patterns.

    Selection: Phenotypic and behavioral abnormalities, shifting of seizure thresholds, and response to anti-seizure medications and other substances.

  3. 3.
    Manipulate neuronal activity and induce seizures with optogenetic tools(functional_characterization)

    This stage provides controlled perturbation of neural activity to probe seizure mechanisms beyond passive phenotype observation.

    Selection: Ability to modify neuronal activity and induce seizures using optogenetic tools.

  4. 4.
    Trace mutation-associated functional alterations with calcium and fluorescent imaging(secondary_characterization)

    This stage adds mechanistic readouts that can connect epilepsy-gene mutations to functional changes.

    Selection: Imaging-based tracing of functional alterations caused by mutations in epilepsy genes.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

They require imaging instrumentation and suitable fluorescent or calcium-based readouts. The abstract does not specify the exact reporters or imaging platform.; requires calcium and/or fluorescent imaging capability; requires a fly model carrying mutations in epilepsy genes

The abstract does not state that imaging alone establishes therapeutic relevance or whole-organism seizure outcomes. It also does not define the limits of sensitivity or throughput.; abstract does not specify imaging reporters, resolution, or quantitative endpoints

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1engineering capabilitysupports2023Source 1needs review

CRISPR/Cas9 is described as a convenient way to generate flies carrying disease-associated variants.

Gene editing techniques, such as CRISPR/Cas9, are a convenient way to generate flies carrying disease-associated variants.
Claim 2functional readoutsupports2023Source 1needs review

Calcium and fluorescent imaging can be used to trace functional alterations caused by mutations in epilepsy genes.

In combination with calcium and fluorescent imaging, functional alterations caused by mutations in epilepsy genes can be traced.
Claim 3phenotype descriptionsupports2023Source 1needs review

Bang-sensitive mutants respond to mechanical stimulation such as a brief vortex with stereotypic seizures and paralysis.

These flies respond to mechanical stimulation, such as a brief vortex, with stereotypic seizures and paralysis.
Claim 4screening capabilitysupports2023Source 1needs review

Variant-carrying flies can be screened for phenotypic and behavioral abnormalities, seizure-threshold shifts, and responses to anti-seizure medications and other substances.

These flies can be screened for phenotypic and behavioral abnormalities, shifting of seizure thresholds, and response to anti-seizure medications and other substances.

Approval Evidence

1 source1 linked approval claimfirst-pass slug calcium-and-fluorescent-imaging
In combination with calcium and fluorescent imaging, functional alterations caused by mutations in epilepsy genes can be traced.

Source:

functional readoutsupports

Calcium and fluorescent imaging can be used to trace functional alterations caused by mutations in epilepsy genes.

In combination with calcium and fluorescent imaging, functional alterations caused by mutations in epilepsy genes can be traced.

Source:

Comparisons

Source-stated alternatives

The abstract also mentions phenotypic and behavioral screening, seizure-threshold assessment, and response-to-medication screening as other readout strategies.

Source:

The abstract also mentions phenotypic and behavioral screening, seizure-threshold assessment, and response-to-medication screening as other readout strategies.

Source-backed strengths

can trace functional alterations when combined with neuronal activity modification approaches

Source:

can trace functional alterations when combined with neuronal activity modification approaches

calcium and fluorescent imaging and Langendorff perfused heart electrical recordings address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

calcium and fluorescent imaging and native green gel system address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

calcium and fluorescent imaging and sub-picosecond pump-probe analysis of bacteriorhodopsin pigments address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

Ranked Citations

  1. 1.
    StructuralSource 1Frontiers in Molecular Neuroscience2023Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl8. Extracted from this source document.